Reimbursement of Patent Costs. Within 30 days after the Effective Date, Licensee will pay OHSU the sum of $9,167.12, which represents Patent Costs incurred by OHSU as of April 30, 2012. Licensee will also reimburse OHSU for all Patent Costs occurring thereafter pursuant to Section 10.2.
Reimbursement of Patent Costs. Notwithstanding the provisions of Section 2.1 hereof, no payment shall be required until Recipient has received reimbursement for all costs associated with the patent of the Technology or with Recipient’s attempt to patent the Technology.
Reimbursement of Patent Costs. 3 2.3 Royalties.................................................. 4 2.3.1
Reimbursement of Patent Costs. Licensee will reimburse Foundation for all Patent Costs incurred, pursuant to Section 6.1, prior to the Effective Date. As of the Effective Date of the Agreement, the accrued patent costs are approximately $170,109.93 which shall be paid to Foundation in three equal installments due on the six (6) month, twelve (12) month and eighteen (18) month anniversaries of the Effective Date of the Agreement. Licensee will pay all Patent Costs incurred after the Effective Date within thirty (30) days after its receipt of an invoice for such Patent Costs.
Reimbursement of Patent Costs. Within [***] after the Technology Addendum Effective Date, Licensee will pay OHSU for any Patent Costs (if any) on the Patent Rights incurred by OHSU as of the date of signing of this Technology Addendum. Licensee agrees to reimburse OHSU for all additional Patent Costs incurred on the Patent Rights within [***] of invoice unless Licensee has surrendered its rights under Section 10.4 of the Agreement.
Reimbursement of Patent Costs. As a part of the consideration ----------------------------- for the exclusive license granted pursuant to Section 2.1 hereof, Licensee shall reimburse Licensor for Licensor's out-of-pocket costs incurred for patent attorney fees and patent application filing fees in connection with the Licensed Patents, up to an aggregate maximum of $25,000. Such reimbursement shall be subject to Licensor's presentation of appropriate documentation of Licensor's payment of such expenses. No payment shall be payable by Licensee hereunder unless and until the issue of the validity of the claims as now stated in the Licensed Patents as described in Section 3.1 hereof is resolved favorably to Licensor's reasonable satisfaction, or, upon the expiration of one (1) year after the date of this Agreement if no request for re-examination of the Licensed Patents is made within such period. All payments made by Licensee to Licensor pursuant to this Section 2.2 shall be credited against Licensee's obligation to pay royalties as set forth in Section 2.3 hereof.
Reimbursement of Patent Costs. Licensee will reimburse Licensor solely for the Patent Costs described below in accordance with Paragraph 4.4 of the Agreement:
1. patent costs incurred after January 3, 2014 for U.S. Licensed Patents, and
2. patent costs incurred after the Effective Date of this Agreement for Licensed Patents that are not U.S. Licensed Patents.
Reimbursement of Patent Costs. Optionee will reimburse OHSU for all Patent Costs occurring during the Term..
Reimbursement of Patent Costs. In the event it is necessary in the opinion of University to file any patent applications to protect a Subject Invention during the Election or Negotiation Periods, Sponsor will reimburse reasonable patent costs incurred by University during such period. If such option or license is not concluded within the Negotiation Period, neither party will have any further obligations to the other with respect to such Subject Invention. If Sponsor does not elect to secure such option or license, rights to such Subject Invention will be disposed of in accordance with University’s policies, with no further obligation to Sponsor with respect to such Subject Invention.
Reimbursement of Patent Costs. (a) Aptamer Option - If.-
(i) Medarex does not exercise the Aptamer Option under paragraph 4. 1, or
(ii) Medarex exercises the Aptamer Option under paragraph 4.1 but does not acquire a license to the CTLA-4 Aptamer, then NeXstar shall reimburse Medarex for [*****] of Regents Past Patent Costs, Regents Foreign Patent Costs and Related Patent Costs paid by Medarex up to such date. NeXstar shall pay this amount to Medarex within 30 days of the last to occur of:
(A) Expiry of the Aptamer Option, or
(B) Expiry of the Aptamer License Option.
